System x c - regulates microglia and macrophage glutamate excitotoxicity in vivo

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 333-341

  Kigerl, Kristina A ^a   Ankeny, Daniel P ^a   Garg, Sanjay K ^b   Wei, Ping ^a   Guan, Zhen ^a   Lai, Wenmin ^a   McTigue, Dana M ^a   Banerjee, Ruma ^b   Popovich, Phillip G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Glutamate; Neuroinflammation; Redox; Spinal cord injury; System x c

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; ANTIPORTER; CYSTEINE ANTIPORTER; GLUTAMATE ANTIPORTER; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENCEPHALITIS; EX VIVO STUDY; EXCITOTOXICITY; EXTRACELLULAR SPACE; IN VIVO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NEURAL STEM CELL; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; OXIDATION REDUCTION REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CYSTINE; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACIDS; GENE EXPRESSION REGULATION; GLUTAMIC ACID; GLUTATHIONE; LASER CAPTURE MICRODISSECTION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE TISSUE PROTEINS; NEURONS; OXIDATION-REDUCTION; QUINOXALINES; SPINAL CORD DISEASES;

EID: 84856225531     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.10.025     Document Type: Article

References (59)

1. Anderson M.E., Underwood M., Bridges R.J., Meister A. Glutathione metabolism at the blood-cerebrospinal fluid barrier. FASEB J. 1989, 3:2527-2531.
2. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., Kalivas P.W. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat. Neurosci. 2003, 6:743-749.
3. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
4. Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 1986, 261:2256-2263.
5. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
6. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
7. Bezzi P., Gundersen V., Galbete J.L., Seifert G., Steinhauser C., Pilati E., Volterra A. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat. Neurosci. 2004, 7:613-620.
8. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992, 587:250-256.
9. - in the brain, kidney, and duodenum. J. Histochem. Cytochem. 2006, 54:549-557.
10. Byrnes K.R., Stoica B., Loane D.J., Riccio A., Davis M.I., Faden A.I. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 2009, 57:550-560.
11. Chong Z.Z., Kang J., Li F., Maiese K. mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. Curr. Neurovasc. Res. 2005, 2:197-211.
12. Chung W.J., Lyons S.A., Nelson G.M., Hamza H., Gladson C.L., Gillespie G.Y., Sontheimer H. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci. 2005, 25:7101-7110.
13. Dobashi K., Aihara M., Araki T., Shimizu Y., Utsugi M., Iizuka K., Murata Y., Hamuro J., Nakazawa T., Mori M. Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione status in human alveolar macrophages. Clin. Exp. Immunol. 2001, 124:290-296.
14. - and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J. Immunol. 2007, 178:6549-6556.
15. Donnelly D.J., Gensel J.C., Ankeny D.P., van Rooijen N., Popovich P.G. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J. Neurosci. Methods 2009, 181:36-44.
16. Droge W., Eck H.P., Gmunder H., Mihm S. Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives. Am. J. Med. 1991, 91:140S-144S.
17. Farso M.C., O'Shea R.D., Beart P.M. Evidence group I mGluR drugs modulate the activation profile of lipopolysaccharide-exposed microglia in culture. Neurochem. Res. 2009, 34:1721-1728.
18. Fogal B., Li J., Lobner D., McCullough L.D., Hewett S.J. System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J. Neurosci. 2007, 27:10094-10105.
19. Gan H.T., Chen Y.Q., Ouyang Q. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 2005, 20:1016-1024.
20. Garg S., Vitvitsky V., Gendelman H.E., Banerjee R. Monocyte differentiation, activation, and mycobacterial killing are linked to transsulfuration-dependent redox metabolism. J. Biol. Chem. 2006, 281:38712-38720.
21. Garg S.K., Banerjee R., Kipnis J. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J. Immunol. 2008, 180:3866-3873.
22. Gensel J.C., Nakamura S., Guan Z., van Rooijen N., Ankeny D.P., Popovich P.G. Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 2009, 29:3956-3968.
23. Glezer I., Chernomoretz A., David S., Plante M.M., Rivest S. Genes involved in the balance between neuronal survival and death during inflammation. PLoS One 2007, 2:e310.
24. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 1998, 780:294-303.
25. Hermann G.E., Rogers R.C., Bresnahan J.C., Beattie M.S. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 2001, 8:590-599.
26. Hosoya K., Saeki S., Terasaki T. Activation of carrier-mediated transport of L-cystine at the blood-brain and blood-retinal barriers in vivo. Microvasc. Res. 2001, 62:136-142.
27. Johnson J.M., Strobel F.H., Reed M., Pohl J., Jones D.P. A rapid LC-FTMS method for the analysis of cysteine, cystine and cysteine/cystine steady-state redox potential in human plasma. Clin. Chim. Acta 2008, 396:43-48.
28. Kigerl K.A., McGaughy V.M., Popovich P.G. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 2006, 494(4):578-594.
29. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50.
30. Kitazawa M., Oddo S., Yamasaki T.R., Green K.N., LaFerla F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 2005, 25:8843-8853.
31. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 2002, 22:2478-2486.
32. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8514-8519.
33. Liu D., Thangnipon W., McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 1991, 547:344-348.
34. Longbrake E.E., Lai W., Ankeny D.P., Popovich P.G. Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J. Neurochem. 2007, 102:1083-1094.
35. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 2003, 3:65-94.
36. McMillian M.K., Vainio P.J., Tuominen R.K. Role of protein kinase C in microglia-induced neurotoxicity in mesencephalic cultures. J. Neuropathol. Exp. Neurol. 1997, 56:301-307.
37. Miller B.A., Sun F., Christensen R.N., Ferguson A.R., Bresnahan J.C., Beattie M.S. A sublethal dose of TNFalpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes. Neurochem. Res. 2005, 30:867-875.
38. Murata Y., Ohteki T., Koyasu S., Hamuro J. IFN-gamma and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur. J. Immunol. 2002, 32:2866-2873.
39. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
40. Noh J.H., Gwag B.J., Chung J.M. Underlying mechanism for NMDA receptor antagonism by the anti-inflammatory drug, sulfasalazine, in mouse cortical neurons. Neuropharmacology 2006, 50:1-15.
41. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 1993, 13:1441-1453.
42. Olney J.W. New mechanisms of excitatory transmitter neurotoxicity. J. Neural Transm. Suppl. 1994, 43:47-51.
43. Penkowa M., Giralt M., Lago N., Camats J., Carrasco J., Hernandez J., Molinero A., Campbell I.L., Hidalgo J. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp. Neurol. 2003, 181:130-148.
44. - in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 1994, 152:3578-3585.
45. Piani D., Frei K., Do K.Q., Cuenod M., Fontana A. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 1991, 133:159-162.
46. Piani D., Spranger M., Frei K., Schaffner A., Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 1992, 22:2429-2436.
47. Popovich P.G., Longbrake E.E. Can the immune system be harnessed to repair the CNS?. Nat. Rev. Neurosci. 2008, 9:481-493.
48. - and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J. Neurosci. 2006, 26:3345-3356.
49. Sasaki H., Sato H., Kuriyama-Matsumura K., Sato K., Maebara K., Wang H., Tamba M., Itoh K., Yamamoto M., Bannai S. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 2002, 277:44765-44771.
50. Sato H., Fujiwara K., Sagara J., Bannai S. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem. J. 1995, 310(Pt 2):547-551.
51. Sato H., Tamba M., Ishii T., Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 1999, 274:11455-11458.
52. Sato H., Tamba M., Okuno S., Sato K., Keino-Masu K., Masu M., Bannai S. Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J. Neurosci. 2002, 22:8028-8033.
53. Schonberg D.L., Popovich P.G., McTigue D.M. Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J. Neuropathol. Exp. Neurol. 2007, 66.
54. Shaw P.J., Forrest V., Ince P.G., Richardson J.P., Wastell H.J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995, 4:209-216.
55. Wade L.A., Brady H.M. Cysteine and cystine transport at the blood-brain barrier. J. Neurochem. 1981, 37:730-734.
56. Wang X.F., Cynader M.S. Astrocytes provide cysteine to neurons by releasing glutathione. J. Neurochem. 2000, 74:1434-1442.
57. 2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J. Neurosci. Res. 2003, 72:508-519.
58. Xu G.Y., Hughes M.G., Ye Z., Hulsebosch C.E., McAdoo D.J. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp. Neurol. 2004, 187:329-336.
59. Ye Z.C., Rothstein J.D., Sontheimer H. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J. Neurosci. 1999, 19:10767-10777.